These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3296728)

  • 1. Hemodynamic effects of pirmenol and lidocaine: a placebo-controlled, double-blind, comparative study.
    Nieminen MS; Toivonen L; Manninen V; Frick H
    Am J Cardiol; 1987 Jun; 59(16):27H-32H. PubMed ID: 3296728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
    Nieminen MS; Toivonen LK; Manninen V; Frick MH
    Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of the antiarrhythmic drug pirmenol.
    Phillips HR; Stack RS; Davis DD; Morris KG; Lee KL; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1982 Aug; 32(2):235-9. PubMed ID: 7094511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of intravenous pirmenol.
    Morris KG; Phillips HR
    Angiology; 1988 Mar; 39(3 Pt 2):321-6. PubMed ID: 3354931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively.
    Toivonen LK; Nieminen MS
    Int J Cardiol; 1986 Feb; 10(2):111-8. PubMed ID: 3943931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of pirmenol and lidocaine on intraventricular conduction in canine myocardial infarction.
    Hashimoto H; Ozaki T; Nagashima S; Nakashima M
    J Electrocardiol; 1991 Oct; 24(4):379-85. PubMed ID: 1744550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of intravenous lidocaine on hemodynamic responses to rapid sequence induction of general anesthesia: a double-blind controlled clinical trial.
    Chraemmer-Jørgensen B; Høilund-Carlsen PF; Marving J; Christensen V
    Anesth Analg; 1986 Oct; 65(10):1037-41. PubMed ID: 3530049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic dose-response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation.
    Jackson N; Verma SP; Frais MA; Silke B; Hafizullah M; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1985 Jun; 37(6):619-24. PubMed ID: 3891187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.
    Anderson JL; Lutz JR; Sanders SW; Nappi JM
    J Cardiovasc Pharmacol; 1983; 5(2):213-20. PubMed ID: 6188892
    [No Abstract]   [Full Text] [Related]  

  • 15. Pirmenol kinetics and effective oral dose.
    Hammill SC; Shand DG; Harrell FE; Zimmerman JM; Reiter MJ; Verghese C; Pritchett EL
    Clin Pharmacol Ther; 1982 Dec; 32(6):686-91. PubMed ID: 7140134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pirmenol hydrochloride in suppressing high frequency ventricular ectopy: a placebo-controlled, double-blind, multicenter study.
    Báguena Candela J
    Am J Cardiol; 1987 Jun; 59(16):48H-52H. PubMed ID: 2438924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter dose-response study of pirmenol hydrochloride in patients with ventricular premature contractions.
    Farnham DJ
    Am J Cardiol; 1987 Jun; 59(16):43H-47H. PubMed ID: 2438923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug.
    Dukes ID; Vaughan Williams EM; Dennis PD
    J Cardiovasc Pharmacol; 1986; 8(2):227-34. PubMed ID: 2422458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.